Harvard University

Faculty Member, Medicine

Other Affiliations: Brigham and Women's Hospital, Medicine. Channing Laboratory

Faculty (Nutritionist, Epidemiologist)

Harvard Medical School and Harvard School of Public Health

About

ERIC DING, PhD, an epidemiologist, nutrition scientist, and health technologist, is currently a faculty member at Harvard Medical School and Brigham and Women’s Hospital. He is also founder and Director of the Campaign for Cancer Prevention (with 6 million members), and Director of Epidemiology with MicroClinic International.

Attending the Johns Hopkins University, graduating with Honors in Public Health and Phi Beta Kappa, he went on and earned his dual doctorate in epidemiology and in nutrition at age 23 from Harvard School of Public Health, as the youngest ever graduate of his double doctoral program. He then completed his postdoctoral fellowship in Nutrition at the Harvard School of Public Health. At Harvard, he taught more than a dozen graduate and undergraduate courses, for which he received the Derek Bok Distinction in Teaching Award from Harvard College.

His research* is focused on risk factors and prevention on chronic disease. He has published in leading journals, including the New England Journal of Medicine, JAMA, The LANCET, and PLoS Medicine. His more than 4 dozen publications have received over 1700 external citations, garnering an H-INDEX impact factor of 17. An invited Google Tech Talk keynote speaker, he has also consulted for the WHO, European Commission, and also served as an appointed expert committee member on Nutritional Expert Group of the WHO Global Burden of Disease Project. His disease burden work has been cited by directors of CDC and CMMS in the framework of the new "Million Hearts" Initiative.

He is a Soros Fellow, of the Paul and Daisy Soros Foundation, recognized for his key role in leading a two-year-long investigation into the controversial drug safety and adverse metabolic risks of Vioxx® that drew national attention. Highlighted and priority published in JAMA, as chief author, he was recognized and named in the New York Times and USA Today in 2006. He was named an 'Oustanding Young Leader' by the Boston Chamber of Commerce in 2012.

A lifelong cancer prevention advocate and childhood tumor survivor, he founded the Campaign for Cancer Prevention, and was featured in Newsweek and The New York Times. He was profiled in the books: CauseWired (Wiley & Sons, Inc 2008), Zilch (Portfolio, Penguin Group 2010), and Shift & Reset (Wiley 2011), and recognized by Craig Newmark as among “16 People and Organizations Changing the World in 2012”. To date, his efforts have raised $500,000 in public donations for disease prevention research. In aggregate outreach, he directs several cancer prevention advocacy platforms totaling over 17 million members, and Facebook pages with more than 7.5 million.

*(His research primarily focuses on obesity and nutritional risk factors for diabetes, heart disease, and expertise include: sex steroid hormones, fatty acids, vitamin D, and cross gender-interactions of obesity, sex hormones, fatty acids, and vitamin D. His research also encompasses social network effects on health, and population nutrition and global health disease burdens. He is also a methodological expert on meta-analysis, evidence-based systematic reviews and Mendelian randomization.)

Contact Information